Antidepressant testing assays

Wednesday, 08 April, 2009 | Supplied by: Beckman Coulter Australia

The DRI Tricyclics Serum Tox Assay leads a panel of three serum tox assays available through Beckman Coulter. The panel includes the DRI Barbiturate Serum Tox Assay and DRI Benzodiazepine Serum Tox Assay.

The Tricyclics Serum Tox Assay is a ready-to-use liquid reagent used for the qualitative and semi-quantitative determination of tricyclic antidepressants in human serum, plasma or urine.

The Benzodiazepine Serum Tox Assay and the Barbiturate Serum Tox Assay are used for the qualitative and semi-quantitative determination of benzodiazepines or barbiturates in human serum or plasma. The panel is therefore suitable for emergency situations where a urine sample may be difficult to obtain.

Each assay features: ready-to-use liquid reagents; onboard reagent stability of 60 days on the Synchron LX and DxC platforms and 30 days on the Synchron CX platform; and the choice of qualitative or semi-quantitative measuring methods.

Phone: 1800 060 878
Related Products

Tecan Crescendo cDNA Synthesis for qPCR kit

Tecan has launched the Crescendo cDNA Synthesis for qPCR system to provide increased sensitivity...

Lonza HLA-typed cells

Lonza now provides an expansive selection of high-resolution human leukocyte antigen (HLA)-typed...

Bio-Rad Laboratories StarBright dyes for flow cytometry

StarBright Blue 700, StarBright Violet 440 and StarBright Violet 610 are fluorescent...

  • All content Copyright © 2020 Westwick-Farrow Pty Ltd